To include your compound in the COVID-19 Resource Center, submit it here.

Arcapta Neohaler regulatory update

FDA approved an NDA from Novartis for 75 µg once-daily Arcapta Neohaler indacaterol for the maintenance treatment of

Read the full 180 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE